These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1107361)

  • 1. Rapid detoxification of the narcotic addict with naloxone hydrochloride. A preliminary report.
    Kurland AA; McCabe L
    J Clin Pharmacol; 1976 Jan; 16(1):66-74. PubMed ID: 1107361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone.
    Resnick RB; Kestenbaum RS; Washton A; Poole D
    Clin Pharmacol Ther; 1977 Apr; 21(4):409-13. PubMed ID: 849672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine and naloxone interactions in methadone maintenance patients.
    Mendelson J; Jones RT; Welm S; Brown J; Batki SL
    Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anesthesia-assisted rapid opiate detoxification: a new procedure in the postanesthesia care unit.
    Wilson LB; DeMaria PA; Kane HL; Reining KM
    J Perianesth Nurs; 1999 Aug; 14(4):207-12; quiz 213-6. PubMed ID: 10745790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment.
    Loimer N; Schmid RW; Presslich O; Lenz K
    J Psychiatr Res; 1989; 23(1):81-6. PubMed ID: 2547057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled comparison of cyclazocine and naloxone treatment of the paroled narcotic addict.
    Hanlon TE; McCabe OL; Savage C; Kurland AA
    Int Pharmacopsychiatry; 1975; 10(4):240-50. PubMed ID: 765293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Forced opioid detoxification under general anesthesia--a new challenge for anesthetists and intensive care physicians].
    Hensel M; Volk T; Kox WJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):261-8. PubMed ID: 10372215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: a comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns.
    Kienbaum P; Scherbaum N; Thürauf N; Michel MC; Gastpar M; Peters J
    Crit Care Med; 2000 Apr; 28(4):969-76. PubMed ID: 10809268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.
    Amass L; Ling W; Freese TE; Reiber C; Annon JJ; Cohen AJ; McCarty D; Reid MS; Brown LS; Clark C; Ziedonis DM; Krejci J; Stine S; Winhusen T; Brigham G; Babcock D; Muir JA; Buchan BJ; Horton T
    Am J Addict; 2004; 13 Suppl 1(Suppl 1):S42-66. PubMed ID: 15204675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone and the narcotic abuser: a low-dose maintenance program.
    Kurland AA; Henderson JM; Krantz JC; Kerman F
    Int J Addict; 1973; 8(1):127-41. PubMed ID: 4351589
    [No Abstract]   [Full Text] [Related]  

  • 11. ["Induced detoxification treatment" of opiate dependent patients--a new therapy concept].
    Loimer N; Presslich O; Lenz K; Pfersmann D; Schmid R; Fodor G; Aschauer G
    Wien Klin Wochenschr; 1989 Jun; 101(13):451-4. PubMed ID: 2763565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrarapid opiate detoxification.
    Bulthuis D; Díaz JE
    Ann Emerg Med; 2000 Jan; 35(1):100-1. PubMed ID: 10613955
    [No Abstract]   [Full Text] [Related]  

  • 13. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical assessment of physical dependence potential of dihydroetorphine hydrochloride (DHE)].
    Ge Y; Li M; Sun WL; Cai ZJ
    Yao Xue Xue Bao; 1994; 29(4):256-60. PubMed ID: 7976340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of pentazocine dependence in hospitalized patients after naloxone administration.
    Sandoval RG; Wang RI
    Psychopharmacologia; 1973 Jun; 30(3):205-15. PubMed ID: 4577443
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: Naloxone.
    Lancet; 1975 Mar; 1(7909):734. PubMed ID: 47492
    [No Abstract]   [Full Text] [Related]  

  • 17. The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trial.
    Beswick T; Best D; Bearn J; Gossop M; Rees S; Strang J
    Am J Addict; 2003; 12(4):295-305. PubMed ID: 14504022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antagonist-induced opiate detoxification. Report on clinical experience as well as on short and intermediate range course].
    Boehle C; Kindgen-Milles D; Burtscheidt W; Tarnow J; Gaebel W
    Nervenarzt; 2000 Sep; 71(9):745-50. PubMed ID: 11042870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
    McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
    Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ultra-rapid detoxification of opiate dependent patients: review of the literature, critiques and proposition for an experimental protocol].
    Fontaine E; Godfroid IO; Guillaume R
    Encephale; 2001; 27(2):187-93. PubMed ID: 11407272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.